There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, ...

The injectable drugs have been in shortage since 2022 ... Zepbound is approved to treat obesity and Mounjaro is approved for diabetes. They use the same active ingredient, tirzepatide.

The Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management.

And because these are relatively new medications, more research is needed to accurately compare the oral and injectable versions. The 2021 review looked specifically at people with diabetes who ...

Learn more about diabetes medications. Medicare Part B covers ... Prescription drug plans, such as Part D, cover injectable insulin and related supplies, including syringes, needles, and gauze.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.